Leaderboard
Anzeige
medline.ch
En
|
De
Impressum
No articles selected!
View Cart
You are here:
Gastroenterology
»
Gastrointestinal
»
Neoplasms
25. August 2026
Search
medline.ch
Neoplasms
Advanced search
Dermatology
Endocrinology
Nutrition
Gastroenterology
Biliary Tract
Liver
Gastrointestinal
Diarrhea
Inflammatory Bowel Disease
Functional Diseases
Gastroenteritis
Gastrointestinal Hemorrhage
Neoplasms
Peptic Ulcer
Others
Esophagus
Pankreas
Gynecology
Haematology
Infectious diseases
Cardiovascular Diseases
Musculoskeletal Diseases
Neurology
Oncology
ORL
Pediatrics
Psychiatry
Respiratory Tract
Sports
Urology-Nephrology
Rect Top
Anzeige
Zoom:
Page 1 of 12202
Articles 1 - 20 / 244033
Preperation of an engineered tryptophan-depleted protein in Pichia pastoris and evaluation of its dietary anti-tumor efficacy.
Sheng Wu Gong Cheng Xue Bao
Dai H, Chen Y, Xie Y, Wang W, Zhou J, Chen J, Yu Y, Lin Y, Huang Y.
PMID: 42638064 [PubMed - indexed for MEDLINE]
Does the level of inferior mesenteric artery ligation affect outcomes in rectal cancer: a meta-analysis.
Clin Transl Oncol
Ji J, Jiang M, Wang D.
PMID: 42638025 [PubMed - as supplied by publisher]
Outcomes of laparoscopic reoperation for anastomotic leak-associated peritonitis following colorectal cancer surgery: a comparative study.
Surg Endosc
Ogawa K, Miyamoto Y, Kawata A, Akiyama T, Arima K, Kosumi K, Eto K, Hadara K, Hiyoshi Y, Iwatsuki M.
PMID: 42637951 [PubMed - as supplied by publisher]
Integrating CT radiomics and morphologic features for preoperative risk stratification of gastrointestinal stromal tumours.
Sci Rep
Denewar FA, Mansour M, Eladl AE, Denewar K, Denewer A, Abdallah A, Saleh GA.
PMID: 42637794 [PubMed - indexed for MEDLINE]
Sustained benefit of adjuvant olaparib in women with germline BRCA1- and BRCA2- -associated high-risk HER2-negative early breast cancer: Updated results from the OlympiA phase III trial.
Ann Oncol
Garber JE, Cameron D, Campbell C, Yothers G, Taboada M, El-Abed S, Rastogi P, McConnell R, Correa A, Delaloge S, Liu WT, Sharma P, Bergh J, Janni W, Balmaña J, Loman N, , Friedman S, Freeman T, Armstrong A, Korde L, Im S, Sagara Y, Viale G, Bliss J, Gianni L, Jóhannsson Ó, Zoppoli G, De Dueñas EM, Marmé F, Fein L, Arnedos M, Ford J, Schmutzler R, Loibl S, Linderholm B, Lakhani SR, Gnant M, Gelmon K, Domchek SM, Senkus E, Eisen A, Jager A, Piccart M, Phillips KA, Traina T, Stickeler E, Singer CF, Shao Z, Liu X, Tipping H, Aktan G, Martinez M, Canon JL, Takahashi M, Yasojima H, Middleton K, Pristauz-Telsnigg G, Pfeiler G, Virani S, Valdes-Albini F, Wolmark N, Mesa ID, Paterson V, Gelber RD, Geyer CE Jr, Tutt ANJ.
PMID: 42636977 [PubMed - as supplied by publisher]
Ifebemtinib plus garsorasib in previously treated metastatic colorectal cancer with KRAS(G12C) mutation: a multicentre, randomised, phase 1b/2 trial.
Lancet Oncol
Song Z, Zhu L, Liu Y, Lin R, Li X, Luo Y, Yuan Y, Shi H, Zhang Y, Zhang B, Zhu Y, Wang Z, Cheng X.
PMID: 42636835 [PubMed - indexed for MEDLINE]
Adjuvant alectinib versus chemotherapy in resected ALK-positive non-small-cell lung cancer (ALINA): health-related quality-of-life and safety outcomes from a randomised, open-label, phase 3 trial.
Lancet Oncol
Dziadziuszko R, Ahn JS, Barlesi F, Solomon BJ, Wu YL, Bondarenko I, Hochmair M, Horinouchi H, Lee DH, Lee JS, Planchard D, Rittmeyer A, Zhong W, Adler L, Archer V, Cardona A, Petric P, Scalori A, Ding B, Mamolo C, Smoljanovic V, Nishio M.
PMID: 42636834 [PubMed - indexed for MEDLINE]
Ivonescimab plus chemotherapy versus placebo plus chemotherapy in patients with advanced EGFR-mutated non-small-cell lung cancer after disease progression on EGFR tyrosine kinase inhibitor therapy (HARMONi): a multicentre, randomised, double-blind, phase 3 trial.
Lancet Oncol
Le X, Passaro A, Zhao Y, Huang Y, Laskin J, Rodriguez-Abreu D, Calles A, Bazhenova L, Lo Russo G, Leighl NB, Cappuzzo F, Girard N, Popat S, Fang W, Luo Y, Li W, He Z, Zhao H, Li M, Song Q, Zhao H, El Darsa H, Monnet I, Cobo Dols M, García Campelo R, Jotte R, Berz D, Spira A, Pérol M, Nagasaka M, West H, Styles L, Li J, Clow F, Goldman J, Zhang L.
PMID: 42636833 [PubMed - indexed for MEDLINE]
Association between PD-1/PD-L1 Expression and Clinicopathological Parameters as well as Prognosis in Neuroendocrine Neoplasms of the Digestive System: A Systematic Review and Meta-Analysis.
Endocr Relat Cancer
Zheng Q, Xie X, Guo Q, Chen C, Jiang W.
PMID: 42636443 [PubMed - as supplied by publisher]
Evaluating longitudinal toxicity and adverse event in cetuximab-treated metastatic colorectal cancer: a pooled analysis from 1,302 patients in ARCAD database.
J Natl Cancer Inst
Yin J, Francis KE, Lopes GS, So J, Olswold CL, Van Cutsem E, Bokemeyer C, Adams R, Chibaudel B, Grothey A, Yoshino T, De Gramont A, Shi Q, Tournigand C, Sjoquist KM, Zalcberg J.
PMID: 42636265 [PubMed - as supplied by publisher]
Hyperthermic intraperitoneal chemotherapy combined with cytoreductive surgery and systemic therapy improves prognosis in colorectal cancer with peritoneal metastases: an updated meta-analysis.
Oncology
Hu K, Hu X, Jiang T, Dai X, Wu Y, Xie Z, Yu Q.
PMID: 42636179 [PubMed - as supplied by publisher]
NHE1 in Gastrointestinal Inflammation and Cancer: A Double-Edged Regulator.
Dig Dis Sci
He C, He T, Tian R, Zhang W, Li Z, Gong Y, Yang C, Qi J, Wan P.
PMID: 42635895 [PubMed - as supplied by publisher]
cGAS-STING Modulates the NF-κB Pathway to Influence the Occurrence of Ulcerative Colitis-Associated Colorectal Cancer.
Dig Dis Sci
Wang J, Luo A, Yao Y, Liu A, Zhu X.
PMID: 42635894 [PubMed - as supplied by publisher]
Primary outcomes of a phase II trial of laparoscopic/robotic total gastrectomy with spleen-preserving splenic hilar dissection for locally advanced proximal gastric cancer involving the greater curvature (JCOG1809).
Gastric Cancer
Kinoshita T, Yokoyama M, Kitadani J, Omori T, Nunobe S, Kuroda S, Honda M, Cho H, Aizawa M, Kurokawa Y, Tsukada T, Haruta S, Misawa K, Ehara K, Kawabata K, Terashima M, Yoshikawa T.
PMID: 42635886 [PubMed - as supplied by publisher]
The dual roles of lysine-specific demethylase 1 (KDM1A/LSD1) in the modulation of tumor immune microenvironment and its inhibitors in colorectal cancer.
J Mol Med (Berl)
Wang YY, Zhou WW, Jia G, Huang XM, Song ZY.
PMID: 42635814 [PubMed - indexed for MEDLINE]
Liquid biopsy in colorectal cancer: redefining surgical decision-making.
Updates Surg
Rausa E, De Grandis MC, Bergamo F, Aiolfi A, Vitellaro M.
PMID: 42635710 [PubMed - as supplied by publisher]
EMB-01, an Anti-EGFR/c-MET Bispecific Antibody, in Patients with Heavily Pretreated Metastatic Colorectal Cancer From a Phase Ib/II, Open-Label, Multicenter Study.
Clin Cancer Res
Xu T, Parseghian CM, Zhang Y, Chen Z, Qin Y, Zhang W, Deng Y, Pan H, Gu S, Li C, Ren F, Wu Y, Lu Q, Zhang M, Wang R, Zhu Y, Shen L, Li J.
PMID: 42635595 [PubMed - as supplied by publisher]
Systematic review: Stereotactic Body Radiation Therapy for Pancreatic Cancer: Evaluating its Efficacy, Safety, and Future Prospects.
Br J Radiol
Sarkar B.
PMID: 42635528 [PubMed - as supplied by publisher]
Use of Complementary and Alternative Medicine for Fatigue and Pain Among Gastrointestinal Cancer Patients in Türkiye: A Cross-Sectional Study.
J Transcult Nurs
Çelik A, Karda.
PMID: 42635435 [PubMed - as supplied by publisher]
Impact of immunotherapy in the treatment of early-stage non-small lung cancer, melanoma, and colorectal cancer.
Immunotherapy
Tartarone A, Conca R, Perrone A, Lerose R.
PMID: 42635261 [PubMed - as supplied by publisher]
Articles 1 - 20 / 244033
Page 1 of 12202
Rect Bottom
Anzeige
Adserver Footer
Time frame
--unlimited--
1 Week
1 Month
3 Months
6 Months
1 Year
2 Years
3 Years
5 Years
10 Years
Sky right 1
Anzeige
Mediscope AG E-mail:
info@mediscope.ch
Disclaimer
|
Privacy Policy